BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
91 hedge funds and large institutions have $134M invested in BioSpecifics Technologies Corp. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 15 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 95 → 91 (-4)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
24% less capital invested
Capital invested by funds: $177M → $134M (-$43M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.46M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.28M |
| 3 |
Two Sigma Investments
New York
|
+$1.12M |
| 4 |
RA
Royce & Associates
New York
|
+$1.04M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$951K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$4.81M |
| 2 |
ACA
Abdiel Capital Advisors
New York
|
-$4.47M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$4.21M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.36M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.21M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Envestnet Asset Management
Chicago,
Illinois
| – | -$48K | -1,107 | Closed |
|
102
Barclays
London,
United Kingdom
| – | -$32K | -761 | Closed |
|
|
BJ
103
BlackRock Japan
Tokyo,
Japan
| – | -$14K | -322 | Closed |
|
104
SEI Investments
Oaks,
Pennsylvania
| – | -$2K | -56 | Closed |
|
|
PMFA
105
Plante Moran Financial Advisors
Southfield,
Michigan
| – | -$1K | -12 | Closed |
|
|
TWA
106
TCI Wealth Advisors
Tucson,
Arizona
| – | +$514 | +14 | New |
|
BSTC Hedge Fund Activity: Q1 2016 in Review
91 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2016, worth a combined $134M — down 24% from $177M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BSTC and 12 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 34 added.
The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $1.46M. The largest seller was EAM Investors, exiting entirely with an estimated $4.81M sold.
- 91 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2016, down from 95 in Q4 2015.
- Funds reported $134M of BioSpecifics Technologies Corp. stock for Q1 2016, down 24% quarter-over-quarter.
- 12 funds opened new BioSpecifics Technologies Corp. positions in Q1 2016 and 15 closed out, a net change of -3 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2016 was DAFNA Capital Management, an estimated $1.46M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2016 was EAM Investors, an estimated $4.81M sold.
Based on aggregated 13F filings for Q1 2016.